Latest Equities News

ECP Emerging Growth Limited reported a modest 2.4% return for FY2025, lagging the ASX Small Ordinaries Index, but is pursuing new strategies including a pre-IPO fund investment and a special dividend to address shareholder value concerns.

MotorCycle Holdings Limited reported a robust 2025 financial year with record revenue and profit growth, strengthened by key acquisitions that expanded its market share to 22%. The company’s focus on operational efficiency and digital transformation sets the stage for continued momentum in 2026.

Noronex Limited’s initial drilling at the Powerline Copper Project in Namibia reveals a promising copper-silver mineralised horizon, validating its geological model and prompting further exploration.

Select Harvests has reported a striking turnaround in FY2025, with net profit soaring to $31.8 million driven by higher almond prices and operational efficiency, while halving its net debt.

Minbos Resources unveils a streamlined strategy for its Cabinda Phosphate Project, cutting upfront costs by $20 million and aiming for accelerated shipments from Porto do Caio in the first half of 2026.

Delorean Corporation has teamed up with Paper Australia (Opal) to explore a renewable energy project at the Maryvale Paper Mill, aiming to convert organic waste into green gas and electricity through anaerobic digestion.

Audeara Limited has secured a $1.22 million R&D tax incentive refund for FY25, strengthening its financial position by repaying debt and retaining non-dilutive funding to fuel ongoing product development.

Straker Limited has significantly narrowed its interim loss despite a 15% revenue decline, driven by cost efficiencies and the absence of prior non-cash charges. The company also renewed a strategic $28 million partnership with IBM, reinforcing its AI language technology ambitions.

West African Resources is advancing negotiations with the Burkina Faso Government over equity interests in its Kiaka gold project, proposing alternatives to direct government ownership to boost national benefits without diluting shareholder value.

Osteopore Limited has drawn an additional A$250,000 under the first tranche of its redeemable convertible notes, continuing its steady capital raise to support growth and innovation.

Zelira Therapeutics has received a $1.07 million cash refund under Australia’s R&D Tax Incentive Scheme, reinforcing its funding for ongoing clinical trials and product development. The company has also repaid a prior loan advanced against this claim, positioning it for continued growth in cannabinoid-based medicines.

Jameson Resources Limited has updated its Employee Share Option Plan, approved at the 2025 AGM, aiming to better incentivize and retain key personnel while aligning employee interests with shareholders.